As cyclin D1-CDK4/6 is crucial for G1 cell cycle progression and generation of neoplastic cells, targeting CDK4/6 could be effective for ESCC patients [29,30,31]. This evidence concerns the gene CCND1 and esophageal squamous cell carcinoma.